Literature DB >> 22482420

Inhibition of advanced glycation end product formation by Pu-erh tea ameliorates progression of experimental diabetic nephropathy.

Shi-Jun Yan1, Lei Wang, Zhi Li, Di-Na Zhu, Shao-Chen Guo, Wen-Feng Xin, Yan-Fang Yang, Xiao Cong, Tao Ma, Pei-Ping Shen, Jun Sheng, Wen-Sheng Zhang.   

Abstract

Accumulation of advanced glycation end products (AGEs) has been implicated in the development of diabetic nephropathy. We investigated the effects of Pu-erh tea on AGE accumulation associated with diabetic nephropathy. Although it did not affect blood glucose levels and insulin sensitivy, Pu-erh tea treatment for 8 weeks attenuated the increases in urinary albumin, serum creatinine, and mesangial matrix in db/db mice. We found that Pu-erh tea prevented diabetes-induced accumulation of AGEs and led to a decreased level of receptor for AGE expression in glomeruli. Both production and clearance of carbonyl compounds, the main precursor of AGE formation, were probably attenuated by Pu-erh tea in vivo independent of glyoxalase I expression. In vitro, HPLC assay demonstrated Pu-erh tea could trap methylglyoxal in a dose-dependent manner. Our study raises the possibility that inhibition of AGE formation by carbonyl trapping is a promising approach to prevent or arrest the progression of diabetic complications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22482420     DOI: 10.1021/jf300347p

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  8 in total

1.  Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.

Authors:  Xianbin Cai; Chongye Fang; Shuhei Hayashi; Shumei Hao; Mingming Zhao; Hiroko Tsutsui; Shuhei Nishiguchi; Jun Sheng
Journal:  J Gastroenterol       Date:  2016-01-21       Impact factor: 7.527

2.  Chinese medicines in the treatment of experimental diabetic nephropathy.

Authors:  Jing-Yi Liu; Xiao-Xin Chen; Sydney Chi-Wai Tang; Stephen Cho-Wing Sze; Yi-Bin Feng; Kai-Fai Lee; Kalin Yan-Bo Zhang
Journal:  Chin Med       Date:  2016-02-24       Impact factor: 5.455

3.  Brain Senescence Caused by Elevated Levels of Reactive Metabolite Methylglyoxal on D-Galactose-Induced Aging Mice.

Authors:  Hong Li; Ling Zheng; Chao Chen; Xiaoli Liu; Wensheng Zhang
Journal:  Front Neurosci       Date:  2019-09-18       Impact factor: 4.677

4.  Ripe and Raw Pu-Erh Tea: LC-MS Profiling, Antioxidant Capacity and Enzyme Inhibition Activities of Aqueous and Hydro-Alcoholic Extracts.

Authors:  Gabriella Roda; Cristina Marinello; Anita Grassi; Claudia Picozzi; Giancarlo Aldini; Marina Carini; Luca Regazzoni
Journal:  Molecules       Date:  2019-01-29       Impact factor: 4.411

Review 5.  Effects and Mechanisms of Tea for the Prevention and Management of Diabetes Mellitus and Diabetic Complications: An Updated Review.

Authors:  Jin-Ming Meng; Shi-Yu Cao; Xin-Lin Wei; Ren-You Gan; Yuan-Feng Wang; Shu-Xian Cai; Xiao-Yu Xu; Pang-Zhen Zhang; Hua-Bin Li
Journal:  Antioxidants (Basel)       Date:  2019-06-10

6.  Pu-erh tea extract induces the degradation of FET family proteins involved in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  Yang Yu; Shuhei Hayashi; Xianbin Cai; Chongye Fang; Wei Shi; Hiroko Tsutsui; Jun Sheng
Journal:  Biomed Res Int       Date:  2014-04-07       Impact factor: 3.411

7.  Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial.

Authors:  Gitte S Jensen; Joni L Beaman; Yi He; Zhixin Guo; Henry Sun
Journal:  Clin Interv Aging       Date:  2016-03-24       Impact factor: 4.458

Review 8.  Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology.

Authors:  Xiao-Fang Yang; Ming Lu; Lijiao You; Huan Gen; Lin Yuan; Tianning Tian; Chun-Yu Li; Kailiang Xu; Jie Hou; Ming Lei
Journal:  Chin Med       Date:  2021-07-27       Impact factor: 5.455

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.